# Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

> **NCT00684008** · PHASE1 · COMPLETED · sponsor: **Cytheris, Inc.** · enrollment: 12 (actual)

## Conditions studied

- AML
- CML
- MDS

## Interventions

- **DRUG:** CYT107 - Recombinant glycosylated human interleukin 7.
- **DRUG:** rhIL-7 (CYT107)

## Key facts

- **NCT ID:** NCT00684008
- **Lead sponsor:** Cytheris, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** —
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684008, "Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00684008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*